JP2002538165A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538165A5
JP2002538165A5 JP2000602260A JP2000602260A JP2002538165A5 JP 2002538165 A5 JP2002538165 A5 JP 2002538165A5 JP 2000602260 A JP2000602260 A JP 2000602260A JP 2000602260 A JP2000602260 A JP 2000602260A JP 2002538165 A5 JP2002538165 A5 JP 2002538165A5
Authority
JP
Japan
Prior art keywords
salt
nucleus
echinocandin
crystals
concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000602260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538165A (ja
JP4063497B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/005494 external-priority patent/WO2000052036A1/en
Publication of JP2002538165A publication Critical patent/JP2002538165A/ja
Publication of JP2002538165A5 publication Critical patent/JP2002538165A5/ja
Application granted granted Critical
Publication of JP4063497B2 publication Critical patent/JP4063497B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000602260A 1999-03-03 2000-03-02 エキノカンジンアンモニウム塩結晶の形成およびアニオン交換 Expired - Lifetime JP4063497B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12307399P 1999-03-03 1999-03-03
US60/123,073 1999-03-03
PCT/US2000/005494 WO2000052036A1 (en) 1999-03-03 2000-03-02 Formation and anion-exchange of crystalline echinocandin ammonium salts

Publications (3)

Publication Number Publication Date
JP2002538165A JP2002538165A (ja) 2002-11-12
JP2002538165A5 true JP2002538165A5 (enExample) 2006-01-05
JP4063497B2 JP4063497B2 (ja) 2008-03-19

Family

ID=22406562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000602260A Expired - Lifetime JP4063497B2 (ja) 1999-03-03 2000-03-02 エキノカンジンアンモニウム塩結晶の形成およびアニオン交換

Country Status (18)

Country Link
US (1) US6590073B2 (enExample)
EP (1) EP1155034B1 (enExample)
JP (1) JP4063497B2 (enExample)
KR (1) KR20020002476A (enExample)
CN (1) CN1351610A (enExample)
AT (1) ATE338060T1 (enExample)
AU (1) AU767956B2 (enExample)
BR (1) BR0009248A (enExample)
CA (1) CA2362826A1 (enExample)
CY (1) CY1105777T1 (enExample)
DE (1) DE60030415T2 (enExample)
DK (1) DK1155034T3 (enExample)
ES (1) ES2270819T3 (enExample)
HK (1) HK1040087A1 (enExample)
IL (1) IL145186A0 (enExample)
PT (1) PT1155034E (enExample)
WO (1) WO2000052036A1 (enExample)
ZA (1) ZA200107999B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
JP2003511345A (ja) 1998-12-09 2003-03-25 イーライ リリー アンド カンパニー Echinocandinシクロペプチド化合物の精製
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
BR0008713A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Processos para preparar formulações ecomposições farmacêuticas orais com ecb
RU2250763C2 (ru) 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
IL145186A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Formation and anion-exchange of crystalline echinocandin ammonium salts
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
TW200826957A (en) 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN102295686A (zh) * 2011-09-09 2011-12-28 杭州华东医药集团生物工程研究所有限公司 一种纽莫康定b0的提取纯化方法
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN105669839B (zh) * 2014-12-05 2019-08-13 重庆乾泰生物医药有限公司 一种棘白菌素b母核或其盐的水合物及制备方法和用途
CN105669840B (zh) * 2014-12-05 2019-06-04 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
WO2020086931A1 (en) * 2018-10-25 2020-04-30 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293482A (en) 1962-06-21 1966-12-20 Rca Corp Plural output traveling wave tube
JPS5134916B2 (enExample) 1974-03-06 1976-09-29
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4293483A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4299763A (en) 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4876241A (en) 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
DK0460882T3 (da) 1990-06-07 1996-08-26 Lilly Co Eli Lipopeptiddeacylase
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
US5198421A (en) 1991-04-26 1993-03-30 Merck & Co., Inc. Phosphorylated cyclic lipopeptide
NZ247149A (en) 1992-03-19 1996-10-28 Lilly Co Eli Cyclic peptide antifungal agents and compositions thereof
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
CA2244238A1 (en) * 1996-02-01 1997-08-07 Eli Lilly And Company Cyclic peptide antifungal agents
JPH1036284A (ja) * 1996-07-24 1998-02-10 Sumitomo Pharmaceut Co Ltd プロテアソーム阻害剤
WO1999006062A1 (en) 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
BR9907967A (pt) * 1998-02-09 2000-10-17 Fujisawa Pharmaceutical Co Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso.
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
ATE287899T1 (de) 1998-08-20 2005-02-15 Lilly Co Eli Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
EP1107982B1 (en) 1998-08-28 2004-05-19 Eli Lilly & Company Reversible boron complexes of 1,2-(cis)-diol cyclic peptides
JP2003511345A (ja) 1998-12-09 2003-03-25 イーライ リリー アンド カンパニー Echinocandinシクロペプチド化合物の精製
JP2002532513A (ja) 1998-12-16 2002-10-02 イーライ リリー アンド カンパニー 糖置換基を有する環式ペプチド抗真菌剤
EP1140991A1 (en) 1998-12-16 2001-10-10 Eli Lilly And Company Cyclic peptide antifungal agents
BR0008713A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Processos para preparar formulações ecomposições farmacêuticas orais com ecb
RU2250763C2 (ru) 1999-03-03 2005-04-27 Эли Лилли Энд Компани Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
IL145186A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Formation and anion-exchange of crystalline echinocandin ammonium salts
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물

Similar Documents

Publication Publication Date Title
JP2002538165A5 (enExample)
AU2001100405B4 (en) Process for the preparation of pure citalopram
JP2022043078A5 (enExample)
JP2005053931A5 (enExample)
JP2003509349A5 (enExample)
JP2008255122A5 (enExample)
JP2004511556A5 (enExample)
JP2010532340A5 (enExample)
JP2006519255A5 (enExample)
JP2003513062A5 (enExample)
JP2001525818A (ja) 新規な中間体およびその製造方法
JP2001261662A5 (enExample)
CN115368310A (zh) 合成甲磺酸酚妥拉明的方法
JP2004529172A5 (enExample)
EP2471795B1 (en) Method for preparing prasugrel
JP2009541290A5 (enExample)
JP2020073513A (ja) α,ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法
JP2005502603A5 (enExample)
JP2004504325A (ja) 高度に純粋な結晶性(r,s)−セフロキシムアキセチルの製法
JP5643844B2 (ja) トピラマート(topiramate)の製造方法
JP2005529082A5 (enExample)
JP2006096734A5 (enExample)
JPWO2009119785A1 (ja) エチニルチミジン化合物の精製方法
JPH08511783A (ja) N−置換アザ複素環式カルボン酸類とそのエステル類
WO2012010106A1 (zh) 溴化吗啡喃季铵盐的制备方法